Clearmind Medicine (CMND) Short Interest Ratio & Short Volume $1.11 +0.21 (+23.15%) Closing price 07/3/2025 03:59 PM EasternExtended Trading$1.10 -0.02 (-1.53%) As of 07/3/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Clearmind Medicine Short Interest DataClearmind Medicine (CMND) has a short interest of 124,900 shares, representing 4.21% of the float (the number of shares available for trading by the public). This marks a 18.16% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 640,151 shares to cover all short positions.Current Short Interest124,900 sharesPrevious Short Interest105,700 sharesChange Vs. Previous Month+18.16%Dollar Volume Sold Short$107.29 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJune 15, 2025Outstanding Shares4,265,000 sharesFloat Size2,970,000 sharesShort Percent of Float4.21%Today's Trading Volume41,810,393 sharesAverage Trading Volume640,151 sharesToday's Volume Vs. Average6,531% Short Selling Clearmind Medicine? Sign up to receive the latest short interest report for Clearmind Medicine and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCMND Short Interest Over TimeCMND Days to Cover Over TimeCMND Percentage of Float Shorted Over Time Clearmind Medicine Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2025124,900 shares $107.29 thousand +18.2%4.2%0.5 $0.86 5/31/2025105,700 shares $102.00 thousand -35.3%3.6%0.4 $0.97 5/15/2025163,300 shares $158.40 thousand -30.3%5.5%0.7 $0.97 4/30/2025234,300 shares $236.64 thousand +98.9%7.9%1.1 $1.01 4/15/2025117,800 shares $108.38 thousand -36.1%4.0%0.5 $0.92 3/31/2025184,400 shares $190.85 thousand -5.2%6.2%2.1 $1.04 3/15/2025194,500 shares $221.73 thousand -23.9%6.5%0.2 $1.14 2/28/2025255,600 shares $309.28 thousand -6.9%8.6%0.3 $1.21 2/15/2025274,600 shares $387.19 thousand -16.0%9.2%0.3 $1.41 1/31/2025326,800 shares $450.98 thousand -20.4%11.0%0.3 $1.38 Get the Latest News and Ratings for CMND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025410,400 shares $627.91 thousand -33.9%13.8%0.4 $1.53 12/31/2024620,700 shares $856.57 thousand +453.7%21.0%0.5 $1.38 12/15/2024112,100 shares $165.16 thousand -41.6%3.8%0.1 $1.47 11/30/2024192,100 shares $249.73 thousand +2.4%6.4%0.8 $1.30 11/15/2024187,600 shares $251.38 thousand -40.8%6.2%0.7 $1.34 10/31/2024316,600 shares $440.07 thousand +45.6%10.5%0.8 $1.39 10/15/2024217,400 shares $345.67 thousand +7.9%7.2%0.6 $1.59 9/30/2024201,400 shares $245.71 thousand -13.2%6.8%0.5 $1.22 9/15/2024231,900 shares $310.75 thousand -5.7%7.8%0.1 $1.34 8/31/2024245,800 shares $322.00 thousand +10.2%8.3%0.1 $1.31 8/15/2024223,100 shares $254.33 thousand -49.2%7.6%0.1 $1.14 7/31/2024439,100 shares $728.91 thousand -2.7%15.0%0.2 $1.66 7/15/2024451,400 shares $1.00 million +32.0%15.5%0.2 $2.22 6/30/2024342,000 shares $574.56 thousand +0.2%11.7%0.1 $1.68 6/15/2024341,200 shares $378.73 thousand +151.8%11.7%0.3 $1.11 5/31/2024135,500 shares $151.76 thousand -44.1%4.6%0.1 $1.12 5/15/2024242,200 shares $310.02 thousand +50.5%8.3%0.2 $1.28 4/30/2024160,900 shares $191.10 thousand +0.4%5.5%0.1 $1.19 4/15/2024160,200 shares $201.85 thousand -10.4%5.5%0.2 $1.26 3/31/2024178,800 shares $205.62 thousand +92.9%6.1%0.1 $1.15 3/15/202492,700 shares $117.73 thousand -59.8%3.2%0.1 $1.27 2/29/2024230,700 shares $355.28 thousand +31.3%7.9%0.1 $1.54 2/15/2024175,700 shares $237.20 thousand +20.0%6.0%0.1 $1.35 1/31/2024146,400 shares $209.35 thousand -83.0%5.4%0.1 $1.43 1/15/2024862,800 shares $1.17 million +5,891.7%52.6%0.4 $1.36 12/31/202314,400 shares $40.46 thousand -65.4%0.9%0 $2.81 12/15/202341,600 shares $116.06 thousand -70.6%2.7%0 $2.79 11/30/2023141,400 shares $494.90 thousand +50.4%26.4%0.1 $3.50 11/15/202394,000 shares $358.14 thousand -70.8%0.7%0 $3.81 10/31/2023322,000 shares $39.25 thousand -90.1%2.5%0.2 $0.12INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)Right now, we’re witnessing a monumental shift in the world.Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia. 10/15/20233,240,000 shares $579.96 thousand +2,129.9%24.3%1.8 $0.18 9/30/2023145,300 shares $23.25 thousand -69.0%1.1%0.3 $0.16 9/15/2023468,400 shares $84.08 thousand +141.3%9.4%1.3 $0.18 8/31/2023194,100 shares $75.93 thousand +106.3%3.9%0.8 $0.39 8/15/202394,100 shares $40.84 thousand -6.2%1.9%0.4 $0.43 7/31/2023100,300 shares $44.13 thousand +6.9%2.0%0.2 $0.44 7/15/202393,800 shares $41.98 thousand -7.5%1.9%0.1 $0.45 6/30/2023101,400 shares $48.17 thousand -31.3%2.0%0.1 $0.48 6/15/2023147,500 shares $80.39 thousand -37.0%2.9%0.1 $0.55 5/31/2023234,000 shares $135.72 thousand -4.4%4.6%0.1 $0.58 5/15/2023244,700 shares $148.53 thousand No Change4.8%0.1 $0.61 CMND Short Interest - Frequently Asked Questions What is Clearmind Medicine's current short interest? Short interest is the volume of Clearmind Medicine shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 124,900 shares of CMND short. 4.21% of Clearmind Medicine's shares are currently sold short. Learn More on Clearmind Medicine's current short interest. What is a good short interest percentage for Clearmind Medicine? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.21% of Clearmind Medicine's floating shares are currently sold short. Is Clearmind Medicine's short interest increasing or decreasing? Clearmind Medicine saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 124,900 shares, an increase of 18.2% from the previous total of 105,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Clearmind Medicine's float size? Clearmind Medicine currently has issued a total of 4,270,000 shares. Some of Clearmind Medicine's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Clearmind Medicine currently has a public float of 2,970,000 shares. How does Clearmind Medicine's short interest compare to its competitors? 4.21% of Clearmind Medicine's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Clearmind Medicine: CASI Pharmaceuticals Inc. (0.33%), Flora Growth Corp. (0.89%), Bullfrog AI Holdings Inc. (4.29%), Acurx Pharmaceuticals, Inc. (2.59%), Edesa Biotech, Inc. (0.54%), X4 Pharmaceuticals, Inc. (12.63%), ProPhase Labs, Inc. (0.47%), VYNE Therapeutics Inc. (2.53%), Synlogic, Inc. (0.53%), Allarity Therapeutics, Inc. (5.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Clearmind Medicine stock? Short selling CMND is an investing strategy that aims to generate trading profit from Clearmind Medicine as its price is falling. CMND shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clearmind Medicine? A short squeeze for Clearmind Medicine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CMND, which in turn drives the price of the stock up even further. How often is Clearmind Medicine's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMND, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies CASI Pharmaceuticals Short Interest Data Flora Growth Short Interest Data Bullfrog AI Short Interest Data Acurx Pharmaceuticals Short Interest Data Edesa Biotech Short Interest Data X4 Pharmaceuticals Short Interest Data ProPhase Labs Short Interest Data VYNE Therapeutics Short Interest Data Synlogic Short Interest Data Allarity Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CMND) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearmind Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearmind Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.